
| Serial Number | 79305516 |
| Word Mark | HEMESIGHT |
| Filing Date | Tuesday, December 15, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 24, 2022 |
| Registration Number | 6733728 |
| Registration Date | Tuesday, May 24, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 8, 2022 |
| Goods and Services | Diagnostic preparations for medical purposes for diagnosing and treating cancer through genetic testing; diagnostic reagents for medical use in diagnosing cancer |
| Pseudo Mark | HEME SIGHT |
| Goods and Services | Providing medical information in the field of genetic and sequencing testing for the diagnosis and treatment of cancer; medical diagnostic services in the nature of performing diagnosis of disease in the field of cancer diagnostics; medical testing for diagnostic or treatment purposes, namely, genetic testing and sequencing tests for diagnosis and treatment of cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 12, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 12, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Otsuka Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Otsuka Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Otsuka Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Monday, March 13, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, October 2, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, September 8, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, September 8, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, August 24, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 24, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 24, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 8, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 8, 2022 | PUBLISHED FOR OPPOSITION |
| Monday, March 7, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, February 16, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 16, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, February 16, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 28, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, January 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, January 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 17, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 16, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 16, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 5, 2021 | REFUSAL PROCESSED BY IB |
| Wednesday, June 16, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, June 16, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, June 11, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, June 10, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 2, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, March 16, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 12, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 11, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, March 4, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |